Cargando…
Early identification of acute heart failure at the time of presentation: do natriuretic peptides make the difference?
BACKGROUND: The early identification of patients with acute heart failure (AHF) is challenging as many other diseases lead to a clinical presentation with dyspnea. AIM: The aim of the study was to evaluate the impact of natriuretic peptides at common HF study cut‐offs on the diagnosis of patients wi...
Autores principales: | Möckel, Martin, von Haehling, Stephan, Vollert, Jörn O., Wiemer, Jan C., Anker, Stefan D., Maisel, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933954/ https://www.ncbi.nlm.nih.gov/pubmed/29667356 http://dx.doi.org/10.1002/ehf2.12290 |
Ejemplares similares
-
The role of procalcitonin in acute heart failure patients
por: Möckel, Martin, et al.
Publicado: (2017) -
Creating an impact, not an impression: ESC Heart Failure in its seventh year
por: von Haehling, Stephan, et al.
Publicado: (2021) -
Open access efforts begin to bloom: ESC Heart Failure gets full attention and first impact factor
por: Anker, Stefan D., et al.
Publicado: (2019) -
Prognostic value of brain natriuretic peptide vs history of heart failure hospitalization in a large real‐world population
por: Zile, Michael R., et al.
Publicado: (2020) -
Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)